Bioventus Inc. (BVS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2019: $2.34M2020: $16.58M2021: $13.52M2022: $1.48M2023: $7.36M2024: $1.01M2025: $2.56M$2.56M
2019Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$2.56M+154.7%
2024$1.01M-86.3%
2023$7.36M+398.1%
2022$1.48M-89.1%
2021$13.52M-18.5%
2020$16.58M+607.9%
2019$2.34M